These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34818317)

  • 21. A Retrospective Assessment of Antecedent Pre-Exposure Prophylaxis Eligibility of HIV-Positive Women in the South.
    Tims-Cook Z
    AIDS Patient Care STDS; 2019 Sep; 33(9):384-387. PubMed ID: 31339737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in Racial and Ethnic Disparities in Estimated Diagnosis Rates of Heterosexually Acquired HIV Infection Among Heterosexual Males in the United States, 2014-2018.
    McCree DH; Chesson HW; Eppink ST; Beer L; Henny KD
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):588-592. PubMed ID: 32925356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Awareness of, interest in, and willingness to pay for HIV pre-exposure prophylaxis among Canadian gay, bisexual, and other men who have sex with men.
    Morgan J; Ferlatte O; Salway T; Wilton J; Hull M
    Can J Public Health; 2018 Dec; 109(5-6):791-799. PubMed ID: 29981103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disparities of HIV risk and PrEP use among transgender women of color in South Florida.
    Holder CL; Perez-Gilbe HR; Fajardo FJ; Garcia S; Cyrus E
    J Natl Med Assoc; 2019 Dec; 111(6):625-632. PubMed ID: 31526532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers to preexposure prophylaxis use among individuals with recently acquired HIV infection in Northern California.
    Marcus JL; Hurley LB; Dentoni-Lasofsky D; Ellis CG; Silverberg MJ; Slome S; Snowden JM; Volk JE
    AIDS Care; 2019 May; 31(5):536-544. PubMed ID: 30304942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing Delivery of HIV Preexposure Prophylaxis for Women in the United States.
    Aaron E; Blum C; Seidman D; Hoyt MJ; Simone J; Sullivan M; Smith DK
    AIDS Patient Care STDS; 2018 Jan; 32(1):16-23. PubMed ID: 29323558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Awareness, Willingness, and Use of Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Washington, DC and Miami-Dade County, FL: National HIV Behavioral Surveillance, 2011 and 2014.
    Patrick R; Forrest D; Cardenas G; Opoku J; Magnus M; Phillips G; Greenberg A; Metsch L; Kharfen M; LaLota M; Kuo I
    J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3(Suppl 3):S375-S382. PubMed ID: 28604442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(31):586-9. PubMed ID: 22874836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community-Informed Development of a Campaign to Increase HIV Pre-exposure Prophylaxis (PrEP) Awareness Among African-American Young Adults.
    Kerr J; Ayangeakaa S; Combs R; Harris L; Sears J; Northington T; Burton K; Sterrett-Hong E; Parker K; Krigger K
    J Racial Ethn Health Disparities; 2021 Aug; 8(4):901-911. PubMed ID: 32869211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in awareness of and willingness to use pre-exposure prophylaxis and anticipated condom use among serodiscordant couples in Taiwan.
    Ko NY; Wu HJ; Strong C; Li CW; Ku WW; Hsu ST
    AIDS Care; 2018 Oct; 30(10):1306-1310. PubMed ID: 29845871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in Awareness of Pre-exposure Prophylaxis and Post-exposure Prophylaxis Among Groups At-Risk for HIV in New York State: New York City and Long Island, NY, 2011-2013.
    Walters SM; Rivera AV; Starbuck L; Reilly KH; Boldon N; Anderson BJ; Braunstein S
    J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3():S383-S391. PubMed ID: 28604443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring Gender Differences in PrEP Interest Among Individuals Testing HIV Negative in an Urban Emergency Department.
    Ridgway J; Almirol E; Schmitt J; Bender A; Anderson G; Leroux I; McNulty M; Schneider J
    AIDS Educ Prev; 2018 Oct; 30(5):382-392. PubMed ID: 30332310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of Awareness, Accessibility and Acceptability of Pre-exposure Prophylaxis (PrEP) Among English- and Spanish-Speaking Latino Men Who have Sex with Men in Los Angeles, California.
    Brooks RA; Landrian A; Lazalde G; Galvan FH; Liu H; Chen YT
    J Immigr Minor Health; 2020 Aug; 22(4):708-716. PubMed ID: 31823164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond the Biomedical: Preexposure Prophylaxis Failures in a Cohort of Young Black Men Who Have Sex With Men in Atlanta, Georgia.
    Serota DP; Rosenberg ES; Lockard AM; Rolle CM; Luisi N; Cutro S; Del Rio C; Siegler AJ; Sanchez TH; Sullivan PS; Kelley CF
    Clin Infect Dis; 2018 Aug; 67(6):965-970. PubMed ID: 29635415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
    Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
    J Miss State Med Assoc; 2015 Dec; 56(12):364-71. PubMed ID: 26975161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State-Level Discrimination Policies And HIV Pre-Exposure Prophylaxis Adoption Efforts In The US.
    Bonett S; Meanley S; Elsesser S; Bauermeister J
    Health Aff (Millwood); 2020 Sep; 39(9):1575-1582. PubMed ID: 32897779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP.
    Calabrese SK; Willie TC; Galvao RW; Tekeste M; Dovidio JF; Safon CB; Blackstock O; Taggart T; Kaplan C; Caldwell A; Kershaw TS
    J Acquir Immune Defic Syndr; 2019 Aug; 81(4):395-405. PubMed ID: 30973543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
    Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
    Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in PrEP Awareness, Discussions with Healthcare Providers, and Use Among Men Who Have Sex with Men in the United States by Urbanicity and Region: A Cross-sectional Analysis.
    Rossiter S; Sharpe JD; Pampati S; Sanchez T; Zlotorzynska M; Jones J
    AIDS Behav; 2021 Dec; 25(12):4102-4114. PubMed ID: 33937963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.